Global Respiratory Inhalers Market – Insights
Respiratory inhalers are used to deliver medication into the body via lungs during the treatment of respiratory diseases such as Chronic Obstructive Pulmonary Disorder (COPD), allergic rhinitis, bronchitis, asthma, pneumonia, and sinusitis. Metered-dose inhalers, dry powder inhalers, and nebulizers are some of the widely used respiratory inhalers.
Global Respiratory Inhalers Market: Drivers
The increasing incidence of COPD is expected to propel the growth of the global respiratory inhalers market over the forecast period. For instance, according to the European Respiratory Society (ERS), 2017, around 65 million people worldwide suffer from moderate to severe COPD. Moreover, increasing the prevalence of asthma is also expected to boost the growth of the market. For instance, according to ERS, 2017, around 334 million people worldwide suffer from asthma.
Note: *The Download PDF brochure only consists of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/227
High incidence of sleep-disordered breathing and occupational lung diseases is expected to aid in the growth of the al respiratory inhalers market over the forecast period. For instance, according to ERS, 2017, around 100 million people worldwide suffer from sleep-disordered breathing and over 50 million people suffer from occupational lung diseases.
Global Respiratory Inhalers Market: Restraints
The availability of alternative treatments such as small molecule drugs, herbs, and vitamins is expected to hinder the growth of the market. For instance, according to the National Center for Biotechnology Information (NCBI), Chinese herb ding-chan tang (DCT) can decrease inflammation and relieve bronchospasm. Other alternative treatments include Yoga (breathing exercises), natural remedies, and others.
Global Respiratory Inhalers Market: Opportunities
Increasing R&D in digital inhalers is expected to offer lucrative growth opportunities for players in the market. Smart inhalers are fitted with sensors, Bluetooth, and a touch-based user interface. Such inhalers also have features such as audio-visual medication alerts, mobile application connectivity, and real-time analysis through cloud-based portals for researchers and clinicians. For instance, in September 2017, Adherium Ltd., a digital health technologies company, received approval from the U.S Food and Drug Administration (FDA) for its SmartTouch inhaler monitoring device to be used with AstraZeneca’s Symbiocort aerosol inhaler.
The global respiratory inhalers market was valued at US$ 30,639.9 million in 2018 and is expected to exhibit a CAGR of 5.7% over the forecast period (2019-2027).
Global Respiratory Inhalers Market – Regional Analysis
On the basis of region, the global respiratory inhalers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to account for the largest market share in the global respiratory inhalers market over the forecast period. This is attributed to high incidence of respiratory diseases in the region. For instance, according to the Centers of Disease Control and Prevention (CDC), in 2018, around 1.3 million people suffered from Emphysema, 7.6 million people had asthma, and 3.4 million people suffered from chronic bronchitis in the U.S.
Need a discount?
Note: *The discount is offered on the Standard Price of the report.
Request discount for this report @ https://www.coherentmarketinsights.com/insight/request-discount/227
The market in Europe is driven by high presence of major market players such as Boehringer Ingelheim GmbH and AstraZeneca Plc. Moreover, key players in the market are focused on product approval and launch, which is also expected to propel growth of the market in Europe. For instance in April 2016, AstraZeneca Plc. received European Commission (EC) approval for Bevespi Aerosphere, which uses AstraZeneca’s Co-suspension technology that enables more than one medicine delivery from a single Metered Dose Inhaler (MDI).
Global Respiratory Inhalers Market: Competitive Landscape
Major players operating in the global respiratory inhalers market include AstraZeneca Plc., Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare, PARI Medical Holding, Teva Pharmaceutical Industries Ltd, and H&T Presspart.
Global Respiratory Inhalers Market: Key Developments
Key players in the market are focused on product approval and launch to expand their product portfolio. For instance, in 2017, Cipla Medpro, a subsidiary of Cipla Ltd., launched Synchrobreathe in South Africa, for the treatment of obstructive airway diseases (OAD) such as asthma.
In September 2017, GlaxoSmithKline plc received approval for Trelegy Ellipta—a once-daily use inhaler triple therapy for the treatment of COPD from the U.S. Food and Drug Administration (FDA).
In April 2019, Glenmark Pharmaceuticals launched two new steroid inhalers that include Soprobec (beclometasone), a metered-dose aerosol inhaler, and Stalpex (salmeterol/fluticasone), a breath-actuated inhaler.
Browse Press Release: http://bit.ly/2NQBqSm
In April 2019, Cipla Ltd. launched Niveoli, an extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, which can be used for the treatment of asthma and COPD.
- Global Respiratory Inhaler Market, By Product Type:
- Dry Powder Inhaler
- Metered Dose Inhaler
- Ultrasonic Nebulizer
- Compressed Air Nebulizer
- Mesh Nebulizer
- Global Respiratory Inhaler Market, By Technology:
- Manually Operated Inhaler Devices
- Digitally Operated Inhaler Devices
- Global Respiratory Inhaler Market, By Disease Indication:
- Pulmonary Arterial Hypertension
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027